相关实验视频

Updated: Jul 22, 2026

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography

Published on: August 16, 2020

中国小细胞肺癌患者脑转移的预后诺莫图:基于人口的现实世界分析

Weili Wang¹, Hongwei Li¹, Sufang Jia¹

¹Department of Radiotherapy, Shanxi Medical University, Shanxi Province Cancer Hospital, Cancer Hospital Affiliated to Shanxi Medical University, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Taiyuan, China.

|November 27, 2025

概括

一个新的预测模型有助于确定小细胞肺癌 (SCLC) 脑转移 (BM) 患者的预后. 这个工具有助于个性化治疗SCLC与BM,改善患者的护理.

科学领域:

在瘤学瘤学.
医学预测医学预测
神经瘤学神经瘤学

背景情况:

小细胞肺癌 (SCLC) 经常转移到大脑 (BM),导致患者的治疗结果不佳.
在SCLC与BM预后存在显著的异质性,需要个性化预测模型.
目前的预后工具可能无法完全捕捉SCLC与BM存活率的复杂性.

研究的目的:

开发和验证一个预测模型,用于预测脑转移小细胞肺癌患者的预后.
确定影响SCLC患者的整体存活率的独立风险因素.
创建一个实用的工具,以指导SCLC与BM的个性化治疗决策.

主要方法:

从2008年1月到2018年12月,对697名患有脑癌的SCLC患者进行了回顾性分析.
在训练队列 (n=526) 上使用单变量和多变量分析开发名录模型.
在独立队列 (n=171) 上验证模型,并与现有的预后评估进行比较.

主要成果:

确定了七个治疗前变量作为SCLC患者的总生存期的独立预测因素.
开发的诺莫格拉姆模型在验证队列中表现出强的表现.
预测模型的表现优于肺部诊断特定的分级预后评估.

结论:

一种新型的诺莫格拉姆模型有效地预测了SCLC患者的预后.
这种工具可以帮助临床医生量身定制治疗策略,区分积极治疗和支持性护理.
进一步的多中心前性研究是有必要的,以确认可概括性和优化治疗方法.

关键词:

大脑转移是大脑转移.一系列的案例系列.这个名字是名ogramogram.总体存活率总体存活率小细胞肺癌是小细胞肺癌.

更多相关视频

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...